Related Experiment Video
Updated: Oct 21, 2025
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
A case of adenocarcinoma of the rete testis with durable response to cisplatin-based chemotherapy
Shunsuke Owa1, Takeshi Sasaki1, Katsunori Uchida2
1Department of Nephro-Urologic Surgery and Andrology Mie University Hospital Tsu Mie Japan.
Introduction:
Adenocarcinoma of the rete testis is a rare malignancy with a poor prognosis. We report a case of adenocarcinoma of the rete testis with a durable response to cisplatin-based chemotherapy.
Case Presentation:
A 48-year-old man with Down syndrome (trisomy 21) presented with a 1-month history of painless swelling of the left scrotum. The physical examination revealed a left testis with a hydrocele associated with a tumor and enlarged pelvic and para-aortic lymph nodes. He underwent a radical orchiectomy. The specimen was diagnosed as adenocarcinoma of the rete testis. The patient received 7 cycles of chemotherapy (1 cycle of BEP and 6 cycles of EP) postoperatively. The metastatic lymph nodes were reduced in size for at least 12 months. Our patient with adenocarcinoma of the rete testis obtained an acceptable response to cisplatin-based chemotherapy.
Conclusion:
We treated a patient with an adenocarcinoma of the rete testis who had an acceptable response to platinum-based chemotherapy.
Related Concept Videos
02:56Treatment Resistant Cancers
01:20Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....